See Our Shortlisted
Thank you to everyone who took the time to vote for your top ADC programs, companies, and individuals for the 12th World ADC Awards. We are pleased to share the 2025 shortlisted nominees, who will be submitting their proposals for the judge’s and ADC Honor Society’s consideration:
Best ADC Platform Technology
- AbClick – AbTis
- AJICAP – Ajinomoto Bio-Pharma Services
- ConjuAll – LigaChem Biosciences
- Conjugation Toolbox - AsymBio
- DXd Technology – Daiichi Sankyo
- GlycoConnect – Synaffix, a Lonza Company
- SMARTag – Catalent
Best New Drug Developer
- Aarvik Therapeutics
- Adcentrx Therapeutics
- Adcytherix
- CrossBridge Bio
- OnCusp Therapeutics
- T-E Meds
Most Promising ADC to Watch
- CS5001 - CStone Pharma
- Emiltatug ledadotin- Mersana Therapeutics
- Fetrastobart vedotin - Pfizer
- IKS014 - Iksuda Therapeutics/Shanghai Fosun Pharmaceutical
- MYTX-011 - Mythic Therapeutics
- PYX-201 - Pyxis Oncology
Best ADC Clinical Impact
- BL-B01D1 – BMS & SystImmune
- DATROWAY - AstraZeneca & Daiichi Sankyo
- EMRELIS - AbbVie
- HER3-DXd - Daiichi Sankyo & Merck & Co.
- PADCEV (Keytruda bladder cancer combination) - Astellas & Pfizer
- Rina-S - GenMab
Best CDMO
- Abzena
- BSP Pharmaceuticals
- Cohance Lifesciences
- Lonza
- MilliporeSigma
- Piramal Pharma Solutions
- WuXi XDC
Best CRO
- Charles River Laboratories
- ChemExpress
- Crown Bioscience
- HUB Organoids
- ICON Plc
- NJ Bio, Inc.
- Precision For Medicine
- Sterling Pharma Solutions
- WuXi XDC
Explore World ADC San Diego's Agenda
Discover the latest industry breakthroughs and insights to be shared at the biggest ADC event, ahead of the awards' gala.
Partner With Us
Position yourself in front of the pioneers trailblazing ADCs to standard of care treatments.
View the 2025 Shortlisted
Have a look at the shortlisted candidates to be recognized this year because of their exceptional work propelling the ADC field to new heights.